➢ Contact Us and Start Your Claim
The diabetes drugs Ozempic and Wegovy (semaglutide) have been linked to an eye condition known as NAION (non-arteritic anterior ischemic optic neuropathy), which can cause eye problems, vision loss, and blindness.
If you or a loved one experienced vision problems after using Wegovy or Ozempic, you may qualify to file a lawsuit and receive compensation for your health condition.
Start your claim today by contacting the lawyers at Hissey Mulderig & Friend. You can call our office toll-free at 1-866-806-8117, or send us a message using our free claims submission form at the top of this page.
➢ Ozempic & Wegovy Linked to Vision Problems
A 2024 study published by JAMA Ophthalmology found that diabetes patients treated with Ozempic and Wegovy (known generically as semaglutide) are more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION), which can cause sudden and potentially permanent vision loss.
According to the study, Ozempic and Wegovy users were four times more likely to be diagnosed with NAION. Among patients who were overweight, the risk of NAION was even higher: eight times more likely.
Although the link between drugs like Ozempic and vision problems is not fully understood by scientists, researchers believe that semaglutide medications may cause changes in blood flow to the optic nerve or lead to sudden drops in blood sugar that harm the eyes.
Since Ozempic and Wegovy are widely used for both diabetes and weight loss, the findings of the JAMA study may affect millions of users across the U.S.
➢ Symptoms of NAION
NAION is the second most common cause of optic nerve damage in adults over 50. This condition is also sometimes referred to as an “eye stroke”.
The most common symptoms experienced by patients diagnosed with NAION include:
- Blindness in one or both eyes
- Blurry vision
- Color blindness or weakened color vision (dyschromatopsia)
- Vision loss (sudden and painless)
Vision loss caused by NAION usually occurs in only one eye. About 15% of patients with this eye condition eventually experience vision loss in their other eye.
The onset of NAION is usually sudden and painless: patients taking Ozempic or Wegovy may notice changes in their vision after waking up from sleep. In less common cases, vision loss from NAION may occur over a period of about two weeks.
➢ Ozempic Lawsuits Allege GLP-1s Linked to NAION
Ozempic and Wegovy patients who have been diagnosed with vision loss or blindness due to NAION may qualify to file a lawsuit and receive compensation for their injury.
The first Ozempic lawsuit involving allegations of vision problems due to NAION was filed in the Spring of 2025. Since then, more than 30 lawsuits have been filed in New Jersey state courts, as well as more than 20 federal lawsuit against the makers of Ozempic.
These lawsuits have alleged that the use of GLP-1 agonists such as Ozempic is linked to an increased risk of NAION or other vision problems, and that patients who were prescribed these medications were not adequately warned about their risk of developing problems with their eyes.
Legal experts predict that many more semaglutide lawsuits could be filed as diabetes patients learn more about the link between drugs like Ozempic and blindness or other vision problems.
➢ Start Your Ozempic or Wegovy Claim Today
Ozempic and Wegovy users who were diagnosed with NAION or who have experienced side effects such as blindness, vision loss, or other eye problems after taking these diabetes drugs may qualify to file a lawsuit and receive compensation for their injuries.
Our law firm, Hissey Mulderig & Friend, is currently representing numerous individuals across the U.S. who have experienced side effects from Ozempic, Wegovy, and other diabetes drugs known as GLP-1 inhibitors.
For more information about filing a Wegovy or Ozempic lawsuit, or to start the process of filing your claim today, contact our law firm by calling toll-free at 1-866-806-8117, or by filling out our free claims submission form at the top of this page.
